PENNINGTONS MANCHES COOPER ADVISES SOURCE HEALTH ECONOMICS ON ITS SALE TO WATERLAND-BACKED SCIRIS
The corporate team at Penningtons Manches Cooper has advised Source Health Economics, an agency specialising in health economics and outcomes research, on its sale to SCIRIS.
Founded in 2016, Source Health Economics comprises a team of specialists in health economics, statistics, medical writing, systematic review, meta-analysis and health technology assessment. The business currently has 33 employees and offices in Oxford and London, and its clients include many of the top ten pharmaceutical companies worldwide.
Backed by private equity firm Waterland, SCIRIS already employs over 300 people across the UK and North America. With a mission to deliver intelligent solutions, inspired by science, it brings together people for exceptional communications and consultancy services, providing bespoke programmes in healthcare communications, creative and brand strategy, market access, medical compliance, and insights.
The team advising Source Health Economics was co-led by corporate partner Will Axtell and senior corporate associate Lindsay Chadwick. The team also included wider support from corporate senior associate Dominique Sabatini, corporate associate Leo Shrimpton, corporate tax partner Kathy Hills, IP managing associate Edmund Forey, IP senior associate Nora Pook, pensions partner Alison Hills, pensions senior associate Clare Coley, real estate associate Lauren Winch and employment associate Luke Shaw.
Juliet Mumby-Croft, co-founder and joint managing director of Source Health Economics, said: “This is a very exciting next step for Source Health Economics. We’re looking forward to working as part of a company that has a shared people-centric ethos and benefiting from the collective wisdom and collaboration that SCIRIS provides. I’d like to thank Will and Lindsay and the wider team at Penningtons Manches Cooper. The PMC team provided us with invaluable expertise and guidance at every step; helping us make sense of the legal complexities and offering pragmatic advice. Their sheer hard work and flexibility was also hugely appreciated; enabling us to meet a very tight timeline!”
Will Axtell, corporate partner at Penningtons Manches Cooper said: “We are delighted to have advised Source Health Economics on their sale to SCIRIS, which will provide them with significant opportunities to continue to expand their business. We wish them all the very best for an exciting future.”
More in Solicitors
Gardner Leader hosts International Women’s Day event
In support of the charity Maths4Girls, Gardner Leader hosted an inspirational morning in Oxford in partnership with Critchleys
Mills & Reeve welcomes new IP and ESG partner set to...
Alex Woolgar joins Mills & Reeve’s Oxford office to support innovative businesses in all stages of growth.
Boardman Hawkins & Osborne LLP join forces with Mayor of Abingdon...
Specialist family law firm Boardman Hawkins & Osborne LLP are helping the Mayor of Abingdon, Gwyneth Lewis, put on an event for International Women’s Day on Friday 8th March at the town’s independently owned Abbey Cinema.
From this author
PENNINGTONS MANCHES COOPER ADVISES THE SHAREHOLDERS OF OXLID ON ITS ACQUISITION...
The corporate team at Penningtons Manches Cooper has advised the shareholders of UK-based OXLiD on its acquisition by AIM listed Anglo-Australian battery innovator, Gelion.
PENNINGTONS MANCHES COOPER APPOINTED AS LEGAL ADVISOR TO ADVANCED RESEARCH +...
Penningtons Manches Cooper’s Birmingham and Oxford offices have been appointed as legal advisors to the Advanced Research + Invention Agency (ARIA), a new R&D agency built to unlock scientific and technological breakthroughs to benefit everyone.
PENNINGTONS MANCHES COOPER ADVISES THE SHAREHOLDERS OF MACHINE VISION TECHNOLOGY SPECIALISTS...
The corporate team at Penningtons Manches Cooper has advised the shareholders of machine vision technology specialists Industrial Vision Systems on its acquisition by Oxford Metrics PLC (LSE: OMG).